NCT03028311Active, not recruitingPhase 1
Yttrium Y-90 Radioembolization in Treating Patients With Metastatic Liver Cancer
Feasibility of Single Session In-Room Yttrium-90 Radioembolization Diagnostic Angiography and Treatment
Source: ClinicalTrials.gov · Last updated 16 Sept 2026
Brief summary (registry, in English)
This clinical trial studies the side effects and best way to perform yttrium Y-90 radioembolization in treating patients with liver cancer that has spread to other places in the body (metastatic). Yttrium Y-90 radioembolization is a therapy that injects radioactive microspheres directly into an artery that feeds liver tumors to cut off their blood supply. Performing yttrium Y-90 radioembolization in a single session may make treatment faster, minimize patient travel, and decrease the overall cost of the procedure.
- Status (registry)
- Active, not recruiting
- Phase (registry)
- Phase 1
- Study type
- Interventional
- Enrollment
- 12 (estimated)
- First submitted
- 19 Jan 2017
- Start date
- 9 Jan 2017
- Primary completion date
- 31 Jan 2027
- Lead sponsor
- M.D. Anderson Cancer Center
- Diseases
- Liver and biliary tract cancer
- NCT number
- NCT03028311
What you commit to
- Study type: Interventional · Phase 1
- Planned participants: 12
- From 9 Jan 2017 to the primary completion date, 31 Jan 2027
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- Patients with greater than 50% liver tumor burden
Who the study is looking for
- The ability to understand and sign informed consent
- Any candidate eligible for standard of care Y90 radioembolization for treatment of their primary or metastatic liver tumors
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| M D Anderson Cancer Center Coordinator of this site? Confirm its status | Houston | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.